Mandana Khalili, MD

Title(s)Professor, Medicine
SchoolSchool of Medicine
Address1001 Potrero Ave, SFGH 5
San Francisco CA 94110
Phone628-206-4766
ORCID ORCID Icon0000-0001-9178-9139 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of OttawaM.D.1992Medicine
    McGill UniversityGastroenterology1997Gastroenterology
    Ochsner Clinic Hepatology1998Hepatology
    UCSFTransplant Hepatology 1999Transplant Hepatology and Post-Doctoral Research
    UCSFM.A.S2005Masters in Advanced Studies in Clinical and Epidemiologic Research
    UCSFMentor Development Program Certificate2007Research Mentoring
    University of California San Francisco2022Diversity, Equity, and Inclusion Champion Training
    Collapse Awards and Honors
    UCSF2022Zuckerberg San Francisco DOM Physician COVID-19 Clinical Service Recognition Award
    Peking Union Medical College, Beijing, China2019Visiting Professor, Department of Scientific Research
    Peking Union Medical College, Beijing, China2018Certificate of Appreciation-Mentor Training Program
    UCSF2017Harold L. Luft Award, Health Disparity Mentoring Award Nomination
    UCSF2016ZSFG Distinction in Medical Education Award Nomination
    UCSF2015Academic Senate Distinction in Mentoring Award Nomination
    NIH2014Mid-Career Investigator Award in Patient Oriented Research
    UCSF2013Academic Senate Distinction in Mentoring Award Nomination
    UCSF2009UCSF University Community Partnerships Council Service Learning Award
    UCSF2008Longitudinal Clinical Experience Appreciation Certificate
    Schering Oncology2001Recognizing Discovery and Innovation in 2001: Milestones in Hepatitis C, Hepatitis Innovation Award
    Gastroenterology Research Group2000American Digestive Health Foundation, Martin Brotman Training and Transition Award
    Canada1988Natural Sciences and Engineering Research Council Award
    McGill University1986J.W. McConnell Entrance Award

    Collapse Overview 
    Collapse Overview
    POSITIONS:
    Chief of Clinical Hepatology, San Francisco General Hospital
    Director, Clinical and Translational Research in Hepatology, San Francisco General Hospital
    Director, Investigator Development Unit, UCSF Research Coordinating Center to Reduce Disparities in Multiple Chronic Diseases (Health Equity Action Network)
    Co-Director, UCSF Mentor Training Program
    Co-Director, UCSF T32 Hepatology Training Program
    Editorial board member, Hepatology Journal

    RESEARCH PROGRAM:
    Mandana Khalili is a Professor of Medicine in the Department of Medicine and Chief of Clinical Hepatology at Zuckerberg San Francisco General Hospital (ZSFG). She also serves as the Director of Clinical and Translational Research in Hepatology at ZSFG. Her research focuses on assessing and addressing health disparities related to viral hepatitis, nonalcoholic fatty liver disease, alcohol-associated liver disease, cirrhosis, and hepatocellular carcinoma including natural history, pathogenesis, metabolic complications, healthcare access and novel treatments. She has a longstanding track record of extramural funding in these areas and has served as PI or co-PI of several NIH-sponsored national and international networks. She currently serves as a PI for the NIDDK-sponsored Liver Cirrhosis Network and also Hepatitis B Research Network assessing the natural history and optimal management of patients with hepatitis B and cirrhosis. Her group previously evaluated mechanisms of insulin resistance and secretion in Latinos with and without hepatitis C infection and is now examining how alcohol affects insulin action and adipose tissue insulin resistance among this at high-risk populations. In collaboration with two VA hospitals, she is evaluating the impact of COVID pandemic and transitions in care delivery on telemedicine satisfaction, quality of life, cirrhosis management, liver cancer screening and substance use among vulnerable populations in order to implement measures and policies to provide equitable liver care. Her group is also evaluating alcohol treatment in patients with liver disease using a novel stepped care motivational interviewing and addiction medicine treatment in the hepatology setting. Additional studies involve hepatitis B, hepatitis C, and liver cancer screening practices and treatment in vulnerable populations receiving care in safety net setting and those experiencing homelessness; aimed at establishing policies to enhance hepatitis B and C elimination efforts. She has been examine knowledge attitudes and barriers to viral hepatitis and fatty liver disease management and implementing novel patient-centered and provider interventions such as education through mobile app to enhance knowledge and motivation and address barriers to care. She is a member of the Liver Cancer San Francisco Cancer Initiative (SF-CAN), which in partnership with the City and County of San Francisco and other health and community partners, is using interventional strategies to reduce cancer in the city. Her group’s recent efforts in developing an integrated model of shelter-based hepatitis C screening and treatment within large homeless shelters in San Francisco and Minnesota has been successful in scaling up hepatitis C management in persons who inject drugs and homeless residents. Dr. Khalili is passionate about mentoring trainees and junior faculty and she has mentored numerous trainee and faculty at all career stages. She is a recipient of a NIH-sponsored K24 award in mentoring junior investigators in liver disease and the co-Director (co-PI) of the T32 Training in Hepatology. She has campus wide leadership roles in mentoring as the Director of UCSF Mentor Training Program. She currently serves as the Director of Investigator Development Unit of the Research Coordinating Center to Reduce Disparities in Multiple Chronic Diseases sponsored by NIMHD. Her diverse research program including translational research, natural history and epidemiology, community/participatory research, health services, and clinical trials provides the infrastructure for supporting junior investigators and in transitioning them to independence.

    WEBSITES
    https://health-equity-action.org/
    http://ctsi.ucsf.edu/about-us/team/programs/career-development-cd
    http://accelerate.ucsf.edu/training/mdp-people
    http://livercenter.ucsf.edu/members/mkhalili.html
    http://ctsi.ucsf.edu/news/about-ctsi/driving-excellence-mentoring-ucsf
    Collapse Global Health Equity

    Collapse Research 
    Collapse Research Activities and Funding
    Racial and Ethnic Disparities in Hepatocellular Carcinoma Surveillance Among Patients with Cirrhosis Across Five Safety Net Organizations
    NIH/NIMHD R01MD017063Dec 22, 2021 - Dec 31, 2026
    Role: UCSF Site Principal Investigator/Co-Investigator
    Liver Cirrhosis Network: Longitudinal and Clinical Trial Studies
    NIH U01DK130168Sep 6, 2021 - Aug 31, 2026
    Role: Principal Investigator
    Research Coordinating Center to Reduce Disparities in Multiple Chronic Diseases (RCC RD-MCD)
    NIH/NIMHD U24MD017250Sep 1, 2021 - Aug 31, 2026
    Role: Director Investigator Skill Development Unit and Co-Investigator
    Impact of the COVID-19 pandemic on patient outcomes, telehealth care delivery, and treatment for unhealthy alcohol use in vulnerable patients with advanced liver disease across two healthcare systems
    NIH R01AA029312Jun 1, 2021 - Feb 28, 2026
    Role: Principal Investigator
    Alcohol's impact on immunological and virological profiles in HIV patients
    NIH/NIAAA UH3AA026218Sep 20, 2019 - Aug 31, 2022
    Role: Co-Investigator
    Mentoring Multidisciplinary Patient-Oriented Research in Liver Disease
    NIH/NIAAA K24AA022523May 1, 2019 - Apr 30, 2024
    Role: Principal investigator
    Mentoring Emerging Scientists for Careers in Substance Use Research
    NIH/NIDA R25DA035163May 1, 2019 - Apr 30, 2024
    Role: Co-Investigator
    Hepatitis B Research Network (HBRN): Natural History and Treatment Studies
    NIH U01DK082944Aug 31, 2015 - May 31, 2022
    Role: Principal Investigator
    HBV-HIV Coinfection Research Network
    NIH/NIDDK R01 DK 094818Sep 23, 2013 - Aug 31, 2019
    Role: Co-Investigator, UCSF Site PI
    Mentoring Multidisciplinary Patient-Oriented Research in Liver Disease
    NIH K24AA022523Aug 1, 2013 - Apr 30, 2024
    Role: Principal Investigator
    Impact of Hepatitis C on Insulin Sensitivity and Insulin Secretion in Latinos
    NIH R01DK074673Apr 1, 2008 - Feb 28, 2015
    Role: Principal Investigator
    HCV-induced alterations in glucose metabolism
    NIH R03DK071531Aug 15, 2005 - Jul 31, 2009
    Role: Principal Investigator
    Insulin Resistance in HCV Infection
    NIH K23DK062013Aug 1, 2002 - Jun 30, 2007
    Role: Principal Investigator
    General Clinical Research Center
    NIH M01RR000083Oct 1, 1974 - Nov 30, 2007
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Collaboration Interests
    Collapse Faculty Mentoring

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Racial/ethnic differences in fibrosis prevalence and progression in biopsy-proven steatosis: A focus on the Asian American population. Hepatol Commun. 2022 Sep 10. Kim RG, Chu JN, Vittinghoff E, Deng J, Reaso JN, Grenert JP, Khalili M. PMID: 36087033.
      View in: PubMed   Mentions:
    2. Undiagnosed abnormal alanine transaminase levels in vulnerable populations: Impact of sex, race/ethnicity, and body mass. Obesity Science and Practice . 2022. Kim, Rebecca G, Khalili, Mandana. View Publication.
    3. Noninvasive Fibrosis Screening in Fatty Liver Disease Among Vulnerable Populations: Impact of Diabetes and Obesity on FIB-4 Score Accuracy. Diabetes Care. 2022 Aug 10. Kim RG, Deng J, Reaso JN, Grenert JP, Khalili M. PMID: 35947698.
      View in: PubMed   Mentions:
    4. Characteristics of Older Patients With Immunotolerant Chronic Hepatitis B Virus Infection. Clin Gastroenterol Hepatol. 2022 Jul 16. Feld JJ, King WC, Ghany MG, Chang KM, Terrault N, Perrillo RP, Khalili M, Hinerman AS, Janssen H, Lok AS, Hepatitis B Research Network (HBRN). PMID: 35843468.
      View in: PubMed   Mentions:    Fields:    
    5. Hepatitis B RNA and Core-Related Antigen Provide Value Beyond DNA in Evaluating e But Not Surface Antigen Clearance. Clin Gastroenterol Hepatol. 2022 Jul 16. King WC, Sterling RK, Hinerman AS, Lok ASF, Cloherty GA, Ghany MG, HBRN HBV Novel Assays Group (Corporate authorship), Wahed AS, Chung RT, Janssen HLA, Khalili M, Lau DTY, Lee WM, Lisker-Melman M, Terrault N. PMID: 35850413.
      View in: PubMed   Mentions:    Fields:    
    6. HBV transcription and translation persist despite viral suppression in HBV-HIV co-infected patients on antiretroviral therapy. Hepatology. 2022 Jun 30. Lisker-Melman M, Wahed AS, Ghany MG, Chung RT, King WC, Kleiner DE, Bhan AK, Khalili M, Jain MK, Sulkowski M, Wong DK, Cloherty G, Sterling RK. PMID: 35770681.
      View in: PubMed   Mentions:    Fields:    
    7. Evolution of Fatty Liver Disease and Relationship With Lipoproteins and Clinical Outcomes in Hepatitis B/Human Immunodeficiency Virus Coinfection. Clin Infect Dis. 2022 06 10; 74(11):1914-1924. Khalili M, King WC, Kleiner DE, Chung RT, Bhan AK, Ghany MG, Sulkowski MS, Lisker-Melman M, Jain MK, Janssen HLA, Hinerman AS, Sanyal AJ, Sterling RK. PMID: 34698347.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    8. A prospective cohort study of renal function and bone turnover in adults with hepatitis B virus (HBV)-HIV co-infection with high prevalence of tenofovir-based antiretroviral therapy use. HIV Med. 2022 May 16. Gizaw A, King WC, Hinerman AS, Chung RT, Lisker-Melman M, Ghany MG, Khalili M, Jain MK, Graham J, Swift-Scanlan T, Kleiner DE, Sulkowski M, Wong DK, Sterling RK, HIV-HBV Cohort Study of the Hepatitis B Research Network. PMID: 35578388.
      View in: PubMed   Mentions:    Fields:    
    9. Coverage, inequity and predictors of hepatitis B birth vaccination in Myanmar from 2011-2016: results from a national survey. BMC Health Serv Res. 2022 Apr 19; 22(1):516. Anderson ACT, Richards A, Delucchi K, Khalili M. PMID: 35436953; PMCID: PMC9016947.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsPHPublic Health
    10. Gaps in Hepatitis A and Hepatitis B Vaccination Among Hepatitis C Antibody-Positive Individuals Experiencing Homelessness. Open Forum Infect Dis. 2022 May; 9(5):ofac175. Partida D, Powell J, Gonzalez D, Khalili M. PMID: 35531381; PMCID: PMC9070334.
      View in: PubMed   Mentions:
    11. Reply to Li, Henry, and Nguyen. Am J Gastroenterol. 2022 Apr 01; 117(4):688. Khalili M, Kleiner DE, King WC, Sterling RK, Ghany MG, Chung RT, Bhan AK, Rosenthal P, Lisker-Melman M, Ramachandran R, Lok AS. PMID: 35158369; PMCID: PMC8976722.
      View in: PubMed   Mentions:    Fields:    
    12. Changes in serum hepatitis B surface and e antigen, interferon-inducible protein 10, and aminotransferase levels during combination therapy of immune-tolerant chronic hepatitis B. Hepatology. 2022 Sep; 76(3):775-787. Perrillo R, Lin HS, Schwarz KB, Rosenthal P, Lisker-Melman M, Chung RT, Prokunina-Olsson L, Coherty G, Feld J, Hepatitis B Research Network (HBRN). PMID: 35188674.
      View in: PubMed   Mentions:    Fields:    
    13. Formal Hepatitis C Education Increases Willingness to Receive Therapy in an On-site Shelter-Based HCV Model of Care in Persons Experiencing Homelessness. Open Forum Infect Dis. 2022 Apr; 9(4):ofac103. Partida D, Powell J, Ricco M, Naugle J, Magee C, Zevin B, Masson CL, Konadu Fokuo J, Gonzalez D, Khalili M. PMID: 35369281; PMCID: PMC8968162.
      View in: PubMed   Mentions: 1  
    14. Soluble Immune Checkpoints Are Dysregulated in COVID-19 and Heavy Alcohol Users With HIV Infection. Front Immunol. 2022; 13:833310. Li W, Syed F, Yu R, Yang J, Xia Y, Relich RF, Russell PM, Zhang S, Khalili M, Huang L, Kacena MA, Zheng X, Yu Q. PMID: 35281051; PMCID: PMC8904355.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    15. Erratum to: Adherence to Hepatitis C Therapy in a Shelter-Based Education and Treatment Model Among Persons Experiencing Homelessness. Open Forum Infect Dis. 2022 Mar; 9(3):ofab652. Powell J, Ricco M, Naugle J, Magee C, Hassan H, Masson C, Braimoh G, Zevin B, Khalili M. PMID: 35224129; PMCID: PMC8865382.
      View in: PubMed   Mentions:
    16. Long-term Follow-up of Hepatitis C Patients Who Achieved Sustained Virologic Response in the Pragmatic PRIORITIZE Study. Clin Gastroenterol Hepatol. 2022 Feb 17. Lok AS, Moon J, Sherman KE, Khalili M, Fishbein D, Reddy KR, PRIORITIZE Study Team. PMID: 35182741.
      View in: PubMed   Mentions:    Fields:    
    17. Incidence and prediction of HBsAg seroclearance in a prospective multi-ethnic HBeAg-negative chronic hepatitis B cohort. Hepatology. 2022 03; 75(3):709-723. Terrault NA, Wahed AS, Feld JJ, Cooper SL, Ghany MG, Lisker-Melman M, Perrillo R, Sterling RK, Khalili M, Chung RT, Rosenthal P, Fontana RJ, Sarowar A, Lau DTY, Wang J, Lok AS, Janssen HLA. PMID: 34743343; PMCID: PMC8943823.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    18. Hepatitis C Screening Among Medicaid Patients With Schizophrenia, 2002-2012. Schizophr Bull Open. 2022 Jan; 3(1):sgab058. Thomas MD, Vittinghoff E, Crystal S, Walkup J, Olfson M, Khalili M, Dahiya P, Keenan W, Cournos F, Mangurian C. PMID: 35059641; PMCID: PMC8763570.
      View in: PubMed   Mentions:
    19. Health Within Reach-a Patient-Centered Intervention to Increase Hepatitis B Screening Among Asian Americans: a Randomized Clinical Trial. J Gen Intern Med. 2022 Jan 06. Khalili M, Kim NJ, Tsoh JY, Walsh JME, Goldman LE, Gildengorin G, Wong C, Tran MT, Yu E, Sharp MT, LeTran VH, Nguyen VV, Nguyen TT. PMID: 34993863.
      View in: PubMed   Mentions:    Fields:    
    20. A Prospective Cohort Study of Novel Markers of Hepatitis B Virus Replication in Human Immunodeficiency Virus Coinfection. Clin Gastroenterol Hepatol. 2021 Dec 29. Chung RT, King WC, Ghany MG, Lisker-Melman M, Hinerman AS, Khalili M, Sulkowski M, Jain MK, Choi EK, Nalesnik MA, Bhan AK, Cloherty G, Wong DK, Sterling RK, HBV-HIV Cohort Study of the Hepatitis B Research Network. PMID: 34973459; PMCID: PMC9240105.
      View in: PubMed   Mentions: 1     Fields:    
    21. Reply. Hepatology. 2022 03; 75(3):761-763. Ghany MG, King WC, Lisker-Melman M, Lok ASF, Terrault N, Janssen HLA, Khalili M, Chung RT, Lee WM, Lau DTY, Cloherty GA, Sterling RK. PMID: 34800047.
      View in: PubMed   Mentions:    Fields:    
    22. Fatty Liver and the Coronavirus Disease 2019 Pandemic: Health Behaviors, Social Factors, and Telemedicine Satisfaction in Vulnerable Populations. Hepatol Commun. 2022 05; 6(5):1045-1055. Kim RG, Medina SP, Magee C, Khalili M. PMID: 34792300; PMCID: PMC8652883.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    23. Disentangling the impact of alcohol use and hepatitis C on insulin action in Latino individuals. Alcohol Clin Exp Res. 2022 01; 46(1):87-99. Kim RG, Kramer-Feldman J, Bacchetti P, Grimes B, Burchard E, Eng C, Hu D, Hellerstein M, Khalili M. PMID: 34773280; PMCID: PMC8799492.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Fatty Liver Disease in a Prospective North American Cohort of Adults With Human Immunodeficiency Virus and Hepatitis B Virus Coinfection. Clin Infect Dis. 2021 11 02; 73(9):e3275-e3285. Khalili M, King WC, Kleiner DE, Jain MK, Chung RT, Sulkowski M, Lisker-Melman M, Wong DK, Ghany M, Sanyal A, Sterling RK. PMID: 32869840; PMCID: PMC8563226.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    25. Shelter-Based Integrated Model Is Effective in Scaling Up Hepatitis C Testing and Treatment in Persons Experiencing Homelessness. Hepatol Commun. 2022 01; 6(1):50-64. Khalili M, Powell J, Park HH, Bush D, Naugle J, Ricco M, Magee C, Braimoh G, Zevin B, Fokuo JK, Masson CL. PMID: 34628726; PMCID: PMC8710795.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    26. Adherence to Hepatitis C Therapy in a Shelter-Based Education and Treatment Model Among Persons Experiencing Homelessness. Open Forum Infect Dis. 2021 Oct; 8(10):ofab488. Powell J, Ricco M, Naugle J, Magee C, Hassan H, Masson C, Braimoh G, Zevin B, Khalili M. PMID: 34651053; PMCID: PMC8507447.
      View in: PubMed   Mentions:
    27. Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America. Hepatology. 2021 11; 74(5):2395-2409. Ghany MG, King WC, Lisker-Melman M, Lok ASF, Terrault N, Janssen HLA, Khalili M, Chung RT, Lee WM, Lau DTY, Cloherty GA, Sterling RK. PMID: 34133774; PMCID: PMC8895675.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    28. A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study. Hepatology. 2021 12; 74(6):2952-2964. Sulkowski MS, Moon JS, Sherman KE, Morelli G, Darling JM, Muir AJ, Khalili M, Fishbein DA, Hinestrosa F, Shiffman ML, Di Bisceglie A, Rajender Reddy K, Pearlman B, Lok AS, Fried MW, Stewart PW, Peter J, Wadsworth S, Kixmiller S, Sloan A, Vainorius M, Horne PM, Michael L, Dong M, Evon DM, Segal JB, Nelson DR, PRIORITIZE Study Team. PMID: 34255381; PMCID: PMC8639765.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsCTClinical Trials
    29. A Prospective Study Evaluating Changes in Histology, Clinical and Virologic Outcomes in HBV-HIV Co-infected Adults in North America. Hepatology. 2021 09; 74(3):1174-1189. Sterling RK, King WC, Khalili M, Chung RT, Sulkowski M, Jain MK, Lisker-Melman M, Ghany MG, Wong DK, Hinerman AS, Bhan AK, Wahed AS, Kleiner DE, HBV-HIV Cohort Study of the Hepatitis B Research Network. PMID: 33743541; PMCID: PMC8597319.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    30. Hepatitis B e antigen loss in adults and children with chronic hepatitis B living in North America: A prospective cohort study. J Viral Hepat. 2021 11; 28(11):1526-1538. Lee WM, King WC, Janssen HLA, Ghany MG, Fontana RJ, Fried M, Sterling RK, Feld JJ, Wang J, Mogul DB, Cooper SL, Bisceglie AMD, Hepatitis B Research Network (HBRN). PMID: 34355475; PMCID: PMC8622507.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    31. Hepatic Steatosis and Steatohepatitis in a Large North American Cohort of Adults With Chronic Hepatitis B. Am J Gastroenterol. 2021 08 01; 116(8):1686-1697. Khalili M, Kleiner DE, King WC, Sterling RK, Ghany MG, Chung RT, Bhan AK, Rosenthal P, Lisker-Melman M, Ramachandran R, Lok AS, ; and the Hepatitis B Research Network (HBRN). PMID: 33840726; PMCID: PMC8484018.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    32. Patient-reported experiences with direct acting antiviral therapy in an integrated model of hepatitis C care in homeless shelters. J Viral Hepat. 2021 10; 28(10):1488-1490. Kim S, Powell J, Naugle J, Ricco M, Magee C, Masson C, Zevin B, Bush D, Khalili M. PMID: 34003525; PMCID: PMC8574070.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    33. Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy. Hepatology. 2021 06; 73(6):2124-2140. Lok AS, Perrillo R, Lalama CM, Fried MW, Belle SH, Ghany MG, Khalili M, Fontana RJ, Sterling RK, Terrault N, Feld JJ, Di Bisceglie AM, Lau DTY, Hassan M, Janssen HLA, Hepatitis B Research Network (HBRN). PMID: 32936969; PMCID: PMC8546406.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    34. Liver disease symptoms are associated with higher risk of adverse clinical outcomes: A longitudinal study of North American adults with chronic Hepatitis B. GastroHep. 2021 May; 3(3):196-208. Evon DM, Lin HS, Fontana RJ, Khalili M, Yim C, Wahed AS, Hoofnagle JH. PMID: 34421369; PMCID: PMC8372034.
      View in: PubMed   Mentions:
    35. Clinical significance of quantitative e antigen in a cohort of hepatitis B virus-infected children and adults in North America. J Viral Hepat. 2021 07; 28(7):1042-1056. Cooper SL, King WC, Mogul DB, Ghany MG, Schwarz KB, Hepatitis B Research Network (HBRN). PMID: 33893706.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    36. Precore and Basal Core Promoter Hepatitis B Virus (HBV) Variants Are Present From a Young Age and Differ Across HBV Genotypes. Hepatology. 2021 05; 73(5):1637-1651. Lau DTY, Ganova-Raeva L, Wang J, Mogul D, Chung RT, Lisker-Melman M, Chang KM, Shaikh OS, Janssen HLA, Wahed AS, Lok AS, Hepatitis B Research Network. PMID: 32860463; PMCID: PMC8570313.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    37. Highly multiplexed 2-dimensional imaging mass cytometry analysis of HBV-infected liver. JCI Insight. 2021 04 08; 6(7). Traum D, Wang YJ, Schwarz KB, Schug J, Wong DK, Janssen H, Terrault NA, Khalili M, Wahed AS, Murray KF, Rosenthal P, Ling SC, Rodriguez-Baez N, Sterling RK, Lau DT, Block TM, Feldman MD, Furth EE, Lee WM, Kleiner DE, Lok AS, Kaestner KH, Chang KM. PMID: 33621209; PMCID: PMC8119221.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    38. Performance of Serum-Based Scores for Identification of Mild Hepatic Steatosis in HBV Mono-infected and HBV-HIV Co-infected Adults. Dig Dis Sci. 2022 02; 67(2):676-688. Sterling RK, King WC, Khalili M, Kleiner DE, Hinerman AS, Sulkowski M, Chung RT, Jain MK, Lisker-Melman MA, Wong DK, Ghany MG, HBV-HIV Cohort Study of the Hepatitis B Research Network. PMID: 33559089.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    39. Rural-Urban Geographical Disparities in Hepatocellular Carcinoma Incidence Among US Adults, 2004-2017. Am J Gastroenterol. 2021 02 01; 116(2):401-406. Wong RJ, Saab S, Konyn P, Sundaram V, Khalili M. PMID: 32976121; PMCID: PMC8136433.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    40. Reply. Hepatol Commun. 2020 Dec; 4(12):1880. Powell J, Khalili M. PMID: 33305157; PMCID: PMC7706309.
      View in: PubMed   Mentions:    Fields:    
    41. Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States. Clin Gastroenterol Hepatol. 2022 01; 20(1):183-193. Kim NJ, Rozenberg-Ben-Dror K, Jacob DA, Rich NE, Singal AG, Aby ES, Yang JD, Nguyen V, Pillai A, Fuchs M, Moon AM, Shroff H, Agarwal PD, Perumalswami P, Chandna S, Zhou K, Patel YA, Latt NL, Wong R, Duarte-Rojo A, Lindenmeyer CC, Frenette C, Ge J, Mehta N, Yao F, Benhammou JN, Bloom PP, Leise M, Kim HS, Levy C, Barnard A, Khalili M, Ioannou GN. PMID: 32927050; PMCID: PMC8657369.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    42. A Patient-Centered Hepatitis B Virus (HBV) Educational Intervention Improves HBV Care Among Underserved Safety-Net Populations. J Clin Gastroenterol. 2020 08; 54(7):642-647. Wong RJ, Khalili M. PMID: 31688365; PMCID: PMC7744280.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    43. Global real-world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts. Liver Int. 2020 08; 40(8):1841-1852. Mangia A, Milligan S, Khalili M, Fagiuoli S, Shafran SD, Carrat F, Ouzan D, Papatheodoridis G, Ramji A, Borgia SM, Wedemeyer H, Losappio R, Pérez-Hernandez F, Wick N, Brown RS, Lampertico P, Doucette K, Ntalla I, Ramroth H, Mertens M, Vanstraelen K, Turnes J. PMID: 32449966; PMCID: PMC7496473.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    44. Clients' perceptions of barriers and facilitators to implementing hepatitis C virus care in homeless shelters. BMC Infect Dis. 2020 May 29; 20(1):386. Masson CL, Fokuo JK, Anderson A, Powell J, Zevin B, Bush D, Khalili M. PMID: 32471376; PMCID: PMC7260732.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    45. Maternal knowledge of the risk of vertical transmission and offspring acquisition of hepatitis B. Ann Hepatol. 2020 Jul - Aug; 19(4):388-395. Lisker-Melman M, Khalili M, Belle SH, Terrault NA, Lin HS, Smith CI, Chung RT, Tsai N, Bzowej NH, Tran TT, Schwarzenberg SJ, Hepatitis B Research Network (HBRN). PMID: 32507734; PMCID: PMC7738313.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    46. Patient Knowledge, Beliefs and Barriers to Hepatitis B Care: Results of a Multicenter, Multiethnic Patient Survey. Dig Dis Sci. 2021 02; 66(2):434-441. Mukhtar NA, Evon DM, Yim C, Lok AS, Lisha N, Lisker-Melman M, Hassan M, Janssen HLA, Khalili M. PMID: 32239377; PMCID: PMC7529692.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    47. Recommendations for Implementing Hepatitis C Virus Care in Homeless Shelters: The Stakeholder Perspective. Hepatol Commun. 2020 May; 4(5):646-656. Fokuo JK, Masson CL, Anderson A, Powell J, Bush D, Ricco M, Zevin B, Ayala C, Khalili M. PMID: 32363316; PMCID: PMC7193125.
      View in: PubMed   Mentions: 12     Fields:    
    48. Alcohol, tobacco and coffee consumption and liver disease severity among individuals with Chronic Hepatitis B infection in North America. Ann Hepatol. 2020 Jul - Aug; 19(4):437-445. Brahmania M, Liu S, Wahed AS, Yim C, Hansen BE, Khalili M, Terrault NA, Lok AS, Ghany M, Wang J, Wong D, Janssen HLA, Hepatitis B Research Network. PMID: 32139262; PMCID: PMC7757603.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    49. Patient-reported outcomes in a large North American cohort living with chronic hepatitis B virus: a cross-sectional analysis. Aliment Pharmacol Ther. 2020 02; 51(4):457-468. Evon DM, Lin HS, Khalili M, Fontana RJ, Yim C, Wahed AS, Fried MW, Hoofnagle JH, Hepatitis B Research Network (HBRN). PMID: 31943262; PMCID: PMC6989387.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    50. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Lancet. 2019 12 14; 394(10215):2184-2196. Younossi ZM, Ratziu V, Loomba R, Rinella M, Anstee QM, Goodman Z, Bedossa P, Geier A, Beckebaum S, Newsome PN, Sheridan D, Sheikh MY, Trotter J, Knapple W, Lawitz E, Abdelmalek MF, Kowdley KV, Montano-Loza AJ, Boursier J, Mathurin P, Bugianesi E, Mazzella G, Olveira A, Cortez-Pinto H, Graupera I, Orr D, Gluud LL, Dufour JF, Shapiro D, Campagna J, Zaru L, MacConell L, Shringarpure R, Harrison S, Sanyal AJ, REGENERATE Study Investigators. PMID: 31813633.
      View in: PubMed   Mentions: 246     Fields:    Translation:HumansCTClinical Trials
    51. Phase Transition Is Infrequent Among North American Adults With e-Antigen-Negative Chronic Hepatitis B and Low-Level Viremia. Am J Gastroenterol. 2019 11; 114(11):1753-1763. Zhou K, Wahed AS, Cooper S, Di Bisceglie AM, Fontana RJ, Ghany MG, Khalili M, Lok AS, Perrillo R, Lee WM, Lau DTY, Sterling R, Janssen HLA, Terrault NA. PMID: 31658127; PMCID: PMC6832838.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    52. Evaluating Noninvasive Markers to Identify Advanced Fibrosis by Liver Biopsy in HBV/HIV Co-infected Adults. Hepatology. 2020 02; 71(2):411-421. Sterling RK, King WC, Wahed AS, Kleiner DE, Khalili M, Sulkowski M, Chung RT, Jain MK, Lisker-Melman M, Wong DK, Ghany MG, HIV-HBV Cohort Study of the Hepatitis B Research Network. PMID: 31220357; PMCID: PMC6923615.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    53. Total Alanine Aminotransferase (ALT) Flares in Pregnant North American Women With Chronic Hepatitis B Infection: Results From a Prospective Observational Study. Am J Gastroenterol. 2019 08; 114(8):1283-1291. Bzowej NH, Tran TT, Li R, Belle SH, Smith CI, Khalili M, Chung R, Tsai N, Terrault N, Hepatitis B Research Network (HBRN). PMID: 31082876; PMCID: PMC7132838.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    54. Hepatitis C Screening in an Underserved U.S. Cohort of Reproductive Age Women. Hepatol Commun. 2019 Sep; 3(9):1183-1190. Kim NJ, Holguin D, Bush D, Khalili M. PMID: 31497740; PMCID: PMC6719736.
      View in: PubMed   Mentions: 2     Fields:    
    55. Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis B. J Viral Hepat. 2019 07; 26(7):856-865. Di Bisceglie AM, King WC, Lisker-Melman M, Khalili M, Belle SH, Feld JJ, Ghany MG, Janssen HLA, Lau D, Lee WM, Ling SC, Cooper S, Rosenthal P, Schwarz KB, Sterling RK, Teckman JH, Terrault N, Hepatitis B Research Network (HBRN). PMID: 30974509; PMCID: PMC6592737.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsPHPublic Health
    56. Spectrum of Liver Disease in Hepatitis B Virus (HBV) Patients Co-infected with Human Immunodeficiency Virus (HIV): Results of the HBV-HIV Cohort Study. Am J Gastroenterol. 2019 05; 114(5):746-757. Sterling RK, Wahed AS, King WC, Kleiner DE, Khalili M, Sulkowski M, Chung RT, Jain MK, Lisker-Melman M, Wong DK, Ghany MG, HIV-HBV Cohort Study of the Hepatitis B Research Network. PMID: 30410040; PMCID: PMC7021442.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    57. Distinct phenotype and function of circulating Vδ1+ and Vδ2+ γδT-cells in acute and chronic hepatitis B. PLoS Pathog. 2019 04; 15(4):e1007715. Chang KM, Traum D, Park JJ, Ho S, Ojiro K, Wong DK, Wahed AS, Terrault NA, Khalili M, Sterling RK, Janssen HLA, Shuhart MC, Lau DT, Roberts LR, Johnson GS, Kaplan DE, Betts MR, Lee WM, Lok ASF, Hepatitis B Research Network (HBRN). PMID: 30998783; PMCID: PMC6490945.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    58. Prevalence and Impact of Hepatitis E Virus Infection Among Persons With Chronic Hepatitis B Living in the US and Canada. Open Forum Infect Dis. 2019 May; 6(5):ofz175. McGivern DR, Lin HS, Wang J, Benzine T, Janssen HLA, Khalili M, Lisker-Melman M, Fontana RJ, Belle SH, Fried MW. PMID: 31139669; PMCID: PMC6527087.
      View in: PubMed   Mentions: 1  
    59. Entecavir and Peginterferon Alfa-2a in Adults With Hepatitis B e Antigen-Positive Immune-Tolerant Chronic Hepatitis B Virus Infection. Hepatology. 2019 06; 69(6):2338-2348. Feld JJ, Terrault NA, Lin HS, Belle SH, Chung RT, Tsai N, Khalili M, Perrillo R, Cooper SL, Ghany MG, Janssen HLA, Lok AS, Hepatitis B Research Network. PMID: 30549279; PMCID: PMC6541521.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    60. Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection. Clin Gastroenterol Hepatol. 2019 11; 17(12):2541-2551.e2. Brahmania M, Lombardero M, Hansen BE, Terrault NA, Lok AS, Perrillo RP, Belle SH, Di Bisceglie AM, Feld JJ, Lee WM, Fried MW, Janssen HLA, Hepatitis B Research Network. PMID: 30743006; PMCID: PMC6905460.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    61. HBV Genotype-Specific Levels of Hepatitis B Surface Antigen Improve HBV Phenotype Definition. Clin Gastroenterol Hepatol. 2020 01; 18(1):259-261. Brouwer WP, Zhao Q, Hansen BE, Lau D, Khalili M, Terrault NA, Di Bisceglie AM, Perrillo RP, Fried MW, Wong D, Feld JJ, Belle SH, Janssen HLA, Hepatitis B Research Network. PMID: 30630104; PMCID: PMC6612468.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    62. Underserved Does Not Mean Undeserved: Unfurling the HCV Care in the Safety Net. Dig Dis Sci. 2018 12; 63(12):3250-3252. Khalili M, Wong RJ. PMID: 30311153; PMCID: PMC6436636.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    63. Liver Disease Monitoring Practices After Hepatitis C Cure in the Underserved Population. Hepatol Commun. 2018 Oct; 2(10):1274-1283. Kim NJ, Magee C, Cummings C, Park H, Khalili M. PMID: 30288480; PMCID: PMC6167066.
      View in: PubMed   Mentions: 6     Fields:    
    64. Race and Hepatitis C Care Continuum in an Underserved Birth Cohort. J Gen Intern Med. 2019 10; 34(10):2005-2013. Kim NJ, Locke CJ, Park H, Magee C, Bacchetti P, Khalili M. PMID: 30238404; PMCID: PMC6816604.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCellsPHPublic Health
    65. Race/ethnicity is an independent risk factor for autoimmune hepatitis among the San Francisco underserved. Autoimmunity. 2018 08; 51(5):258-264. Lee B, Holt EW, Wong RJ, Sewell JL, Somsouk M, Khalili M, Maher JJ, Tana MM. PMID: 29890851; PMCID: PMC6311708.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    66. Direct Acting Antivirals Improve HCV Treatment Initiation and Adherence Among Underserved African Americans. Ann Hepatol. 2018 May-June; 17(3):413-418. Beck KR, Kim NJ, Khalili M. PMID: 29735789; PMCID: PMC7058131.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    67. Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B. Diabetes Care. 2018 06; 41(6):1251-1259. Khalili M, Shuhart MC, Lombardero M, Feld JJ, Kleiner DE, Chung RT, Terrault NA, Lisker-Melman M, Sanyal A, Lok AS, Hepatitis B Research Network (HBRN), Harvard Consortium. PMID: 29599296; PMCID: PMC5961397.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    68. Impact of Moderate Alcohol Discontinuation on Insulin Action and Secretion in Latinos With and Without Hepatitis C. Alcohol Clin Exp Res. 2018 Mar; 42(3):492-499. Uribe LA, Bacchetti P, Gelman N, Burchard E, Fitch M, Hellerstein M, Khalili M. PMID: 29220547; PMCID: PMC5832577.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    69. Hospitalizations for Autoimmune Hepatitis Disproportionately Affect Black and Latino Americans. Am J Gastroenterol. 2018 02; 113(2):243-253. Wen JW, Kohn MA, Wong R, Somsouk M, Khalili M, Maher J, Tana MM. PMID: 29380822; PMCID: PMC6522224.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    70. Memory T Cell Proliferation before Hepatitis C Virus Therapy Predicts Antiviral Immune Responses and Treatment Success. J Immunol. 2018 02 01; 200(3):1124-1132. Méndez-Lagares G, Lu D, Chen C, Terrault N, Segal MR, Khalili M, Monto A, Shen H, Manos MM, Lanier LL, Ryan JC, McCune JM, Hartigan-O'Connor DJ. PMID: 29263212; PMCID: PMC5780234.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    71. Provider, Patient, and Practice Factors Shape Hepatitis B Prevention and Management by Primary Care Providers. J Clin Gastroenterol. 2017 Aug; 51(7):626-631. Mukhtar NA, Kathpalia P, Hilton JF, Lau G, Yu A, Grumbach K, Nguyen TT, Chan D, Khalili M. PMID: 27811627; PMCID: PMC5413438.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    72. Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment. J Viral Hepat. 2017 11; 24(11):1032-1042. Lok AS, Ganova-Raeva L, Cloonan Y, Punkova L, Lin HS, Lee WM, Ghany MG, Hepatitis B Research Network (HBRN). PMID: 28581155; PMCID: PMC5638682.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsPHPublic Health
    73. Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection. N Engl J Med. 2017 06 01; 376(22):2134-2146. Bourlière M, Gordon SC, Flamm SL, Cooper CL, Ramji A, Tong M, Ravendhran N, Vierling JM, Tran TT, Pianko S, Bansal MB, de Lédinghen V, Hyland RH, Stamm LM, Dvory-Sobol H, Svarovskaia E, Zhang J, Huang KC, Subramanian GM, Brainard DM, McHutchison JG, Verna EC, Buggisch P, Landis CS, Younes ZH, Curry MP, Strasser SI, Schiff ER, Reddy KR, Manns MP, Kowdley KV, Zeuzem S, POLARIS-1 and POLARIS-4 Investigators. PMID: 28564569.
      View in: PubMed   Mentions: 146     Fields:    Translation:HumansCellsCTClinical Trials
    74. Determination of hepatitis B phenotype using biochemical and serological markers. J Viral Hepat. 2017 04; 24(4):320-329. Di Bisceglie AM, Lombardero M, Teckman J, Roberts L, Janssen HL, Belle SH, Hoofnagle JH, Hepatitis B Research Network (HBRN). PMID: 27917600; PMCID: PMC5733779.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    75. Sofosbuvir-Containing Regimens for Chronic Hepatitis C Are Successful in the Safety-Net Population: A Real-World Experience. Dig Dis Sci. 2016 12; 61(12):3602-3608. Beck KR, Kim N, Khalili M. PMID: 27743164; PMCID: PMC5106301.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    76. Moderate Alcohol Use and Insulin Action in Chronic Hepatitis C Infection. Dig Dis Sci. 2016 08; 61(8):2417-2425. Burman BE, Bacchetti P, Khalili M. PMID: 27007134; PMCID: PMC4945365.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    77. Hepatitis C Screening Rate Among Underserved Adults With Serious Mental Illness Receiving Care in California Community Mental Health Centers. Am J Public Health. 2016 Apr; 106(4):740-2. Trager E, Khalili M, Masson CL, Vittinghoff E, Creasman J, Mangurian C. PMID: 26890183; PMCID: PMC4816001.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansPHPublic Health
    78. Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN). Dig Dis Sci. 2016 Apr; 61(4):1186-96. Evon DM, Wahed AS, Johnson G, Khalili M, Lisker-Melman M, Fontana RJ, Sarkar S, Reeve BB, Hoofnagle JH. PMID: 26831489; PMCID: PMC4791302.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    79. Hepatitis B Virus--Specific and Global T-Cell Dysfunction in Chronic Hepatitis B. Gastroenterology. 2016 Mar; 150(3):684-695.e5. Park JJ, Wong DK, Wahed AS, Lee WM, Feld JJ, Terrault N, Khalili M, Sterling RK, Kowdley KV, Bzowej N, Lau DT, Kim WR, Smith C, Carithers RL, Torrey KW, Keith JW, Levine DL, Traum D, Ho S, Valiga ME, Johnson GS, Doo E, Lok AS, Chang KM, Hepatitis B Research Network. PMID: 26684441; PMCID: PMC4766024.
      View in: PubMed   Mentions: 84     Fields:    Translation:HumansCells
    80. Impact of gender and menopausal status on metabolic parameters in chronic hepatitis C infection. J Viral Hepat. 2016 Mar; 23(3):232-9. Gonzales CA, Bacchetti P, Khalili M. PMID: 26554398; PMCID: PMC4809676.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    81. Is there a relationship between hepatitis B surface antibody status and diabetes? J Diabetes. 2016 Jan; 8(1):36-7. Khalili M, Sanyal A. PMID: 26201556.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    82. Diabetes and prediabetes in patients with hepatitis B residing in North America. Hepatology. 2015 Nov; 62(5):1364-74. Khalili M, Lombardero M, Chung RT, Terrault NA, Ghany MG, Kim WR, Lau D, Lisker-Melman M, Sanyal A, Lok AS, HBRN. PMID: 26390278; PMCID: PMC4762364.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    83. Reasons for HCV non-treatment in underserved African Americans: implications for treatment with new therapeutics. Ann Hepatol. 2015 Mar-Apr; 14(2):234-42. Schaeffer S, Khalili M. PMID: 25671833; PMCID: PMC4384428.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    84. The birth and potential death of IL28B genotyping for hepatitis C therapy. Per Med. 2015 Mar; 12(2):55-57. Wu AH, Khalili M. PMID: 29754535.
      View in: PubMed   Mentions: 1     Fields:    
    85. Assessment of HBV preventive services in a medically underserved Asian and Pacific Islander population using provider and patient data. J Gen Intern Med. 2015 Jan; 30(1):68-74. Mukhtar NA, Toy BC, Burman BE, Yu A, Chen AH, Berman P, Nguyen T, Chan D, Hammer H, McCulloch CE, Khalili M. PMID: 25324148; PMCID: PMC4284271.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    86. Liver inflammation is a risk factor for prediabetes in at-risk latinos with and without hepatitis C infection. Liver Int. 2015 Jan; 35(1):101-7. Burman BE, Bacchetti P, Ayala CE, Gelman N, Melgar J, Khalili M. PMID: 25156890; PMCID: PMC4293255.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    87. Depression is not associated with peripheral insulin resistance in patients with chronic hepatitis C infection. J Viral Hepat. 2015 Mar; 22(3):272-80. Shah SC, Kornak J, Khalili M. PMID: 25196736; PMCID: PMC4386832.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    88. Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype. Clin Gastroenterol Hepatol. 2015 Jan; 13(1):183-92. Ghany MG, Perrillo R, Li R, Belle SH, Janssen HL, Terrault NA, Shuhart MC, Lau DT, Kim WR, Fried MW, Sterling RK, Di Bisceglie AM, Han SH, Ganova-Raeva LM, Chang KM, Lok AS, Hepatitis B Research Network, Hepatitis B Research Network. PMID: 25010003; PMCID: PMC4268271.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCells
    89. Education and counseling in the methadone treatment setting improves knowledge of viral hepatitis. J Subst Abuse Treat. 2014 Apr; 46(4):528-31. Larios SE, Masson CL, Shopshire MS, Hettema J, Jordan AE, McKnight C, Young C, Khalili M, Seewald RM, Min A, Hengl N, Sorensen JL, Des Jarlais DC, Perlman DC. PMID: 24462241; PMCID: PMC4019752.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    90. Hepatitis B management in vulnerable populations: gaps in disease monitoring and opportunities for improved care. Dig Dis Sci. 2014 Jan; 59(1):46-56. Burman BE, Mukhtar NA, Toy BC, Nguyen TT, Chen AH, Yu A, Berman P, Hammer H, Chan D, McCulloch CE, Khalili M. PMID: 24052195; PMCID: PMC3947196.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansPHPublic Health
    91. A randomized trial of a hepatitis care coordination model in methadone maintenance treatment. Am J Public Health. 2013 Oct; 103(10):e81-8. Masson CL, Delucchi KL, McKnight C, Hettema J, Khalili M, Min A, Jordan AE, Pepper N, Hall J, Hengl NS, Young C, Shopshire MS, Manuel JK, Coffin L, Hammer H, Shapiro B, Seewald RM, Bodenheimer HC, Sorensen JL, Des Jarlais DC, Perlman DC. PMID: 23947319; PMCID: PMC3853128.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansPHPublic Health
    92. Hepatocellular screening in hepatitis-B infected Asian Americans. J Viral Hepat. 2013 Jul; 20(7):515-6. Khalili M, Stewart S. PMID: 23730847; PMCID: PMC4384647.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    93. Formal hepatitis C education enhances HCV care coordination, expedites HCV treatment and improves antiviral response. Liver Int. 2013 Aug; 33(7):999-1007. Lubega S, Agbim U, Surjadi M, Mahoney M, Khalili M. PMID: 23509897; PMCID: PMC3692599.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    94. Insulin sensitivity and variability in hepatitis C virus infection using direct measurement. Dig Dis Sci. 2013 Apr; 58(4):1141-8. Mukhtar NA, Bacchetti P, Ayala CE, Melgar J, Christensen S, Maher JJ, Khalili M. PMID: 23086116; PMCID: PMC3566265.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    95. A mentor development program for clinical translational science faculty leads to sustained, improved confidence in mentoring skills. Clin Transl Sci. 2012 Aug; 5(4):362-7. Feldman MD, Steinauer JE, Khalili M, Huang L, Kahn JS, Lee KA, Creasman J, Brown JS. PMID: 22883616; PMCID: PMC3582327.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    96. Impact of insulin resistance on HCV treatment response and impact of HCV treatment on insulin sensitivity using direct measurements of insulin action. Diabetes Care. 2012 May; 35(5):1090-4. Brandman D, Bacchetti P, Ayala CE, Maher JJ, Khalili M. PMID: 22399695; PMCID: PMC3329815.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCellsCTClinical Trials
    97. Hepatocellular carcinoma screening practices and impact on survival among hepatitis B-infected Asian Americans. J Viral Hepat. 2012 Aug; 19(8):594-600. Sarkar M, Stewart S, Yu A, Chen MS, Nguyen TT, Khalili M. PMID: 22762144; PMCID: PMC3390753.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    98. Assessment of factors associated with pre-diabetes in HCV infection including direct and dynamic measurements of insulin action. J Viral Hepat. 2012 Jul; 19(7):480-7. Mukhtar NA, Ayala C, Maher JJ, Khalili M. PMID: 22676360; PMCID: PMC3375865.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    99. Racial differences in hepatitis C treatment eligibility. Hepatology. 2011 Jul; 54(1):70-8. Melia MT, Muir AJ, McCone J, Shiffman ML, King JW, Herrine SK, Galler GW, Bloomer JR, Nunes FA, Brown KA, Mullen KD, Ravendhran N, Ghalib RH, Boparai N, Jiang R, Noviello S, Brass CA, Albrecht JK, McHutchison JG, Sulkowski MS, IDEAL Study Team. PMID: 21488082; PMCID: PMC3736356.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansPHPublic Health
    100. Hepatitis B and hepatocellular carcinoma screening among Asian Americans: survey of safety net healthcare providers. Dig Dis Sci. 2011 May; 56(5):1516-23. Khalili M, Guy J, Yu A, Li A, Diamond-Smith N, Stewart S, Chen M, Nguyen T. PMID: 21046247; PMCID: PMC3082048.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    101. Formal patient education improves patient knowledge of hepatitis C in vulnerable populations. Dig Dis Sci. 2011 Jan; 56(1):213-9. Surjadi M, Torruellas C, Ayala C, Yee HF, Khalili M. PMID: 20972850; PMCID: PMC3008930.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    102. Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate. Gastroenterology. 2010 Nov; 139(5):1602-11, 1611.e1. Sulkowski MS, Shiffman ML, Afdhal NH, Reddy KR, McCone J, Lee WM, Herrine SK, Harrison SA, Poordad FF, Koury K, Deng W, Noviello S, Pedicone LD, Brass CA, Albrecht JK, McHutchison JG, IDEAL Study Team. PMID: 20723545.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    103. Comparison of surrogate and direct measurement of insulin resistance in chronic hepatitis C virus infection: impact of obesity and ethnicity. Hepatology. 2010 Jul; 52(1):38-46. Lam KD, Bacchetti P, Abbasi F, Ayala CE, Loeb SM, Shah V, Wen MJ, Reaven GM, Maher JJ, Khalili M. PMID: 20578127; PMCID: PMC4391817.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    104. A glimpse of future hepatitis C virus treatment paradigms. Hepatology. 2010 Feb; 51(2):707-10. Terrault N, Khalili M. PMID: 20104511.
      View in: PubMed   Mentions: 1     Fields:    
    105. Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection. N Engl J Med. 2009 Aug 06; 361(6):580-93. McHutchison JG, Lawitz EJ, Shiffman ML, Muir AJ, Galler GW, McCone J, Nyberg LM, Lee WM, Ghalib RH, Schiff ER, Galati JS, Bacon BR, Davis MN, Mukhopadhyay P, Koury K, Noviello S, Pedicone LD, Brass CA, Albrecht JK, Sulkowski MS, IDEAL Study Team. PMID: 19625712.
      View in: PubMed   Mentions: 340     Fields:    Translation:HumansCells
    106. Long-term histological effects of preemptive antiviral therapy in liver transplant recipients with hepatitis C virus infection. Liver Transpl. 2008 Oct; 14(10):1491-7. Kuo A, Tan V, Lan B, Khalili M, Feng S, Roberts JP, Terrault NA. PMID: 18825708.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    107. Coinfection with Hepatitis Viruses and HIV Update. In: Peiperl L, Volberding PA, eds. HIV InSite Knowledge Base [textbook on-line]. 2006. Khalili M.
    108. Management of hepatitis C-infected liver transplant recipients at large North American centres: changes in recent years. Clin Transplant. 2006 Jan-Feb; 20(1):1-9. Khalili M, Vardanian AJ, Hamerski CM, Wang R, Bacchetti P, Roberts JP, Terrault NA. PMID: 16556146.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    109. Pegylated interferon alpha-2a with or without ribavirin in HCV/HIV coinfection: partially blinded, randomized multicenter trial. Dig Dis Sci. 2005 Jun; 50(6):1148-55. Khalili M, Bernstein D, Lentz E, Barylski C, Hoffman-Terry M. PMID: 15986873.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    110. Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation. Am J Transplant. 2005 Jan; 5(1):118-24. Shergill AK, Khalili M, Straley S, Bollinger K, Roberts JP, Ascher NA, Terrault NA. PMID: 15636619.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCTClinical Trials
    111. Relative effects of insulin resistance and protease inhibitor treatment on lipid and lipoprotein metabolism in HIV-infected patients. HIV Clin Trials. 2004 Nov-Dec; 5(6):383-91. Beatty G, Chu J, Kulkarni K, Lipshutz G, Khalili M, Abbasi F, Stansell J, Reaven GM. PMID: 15682351.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    112. Treatment of the hepatitis C virus in patients coinfected with HIV. Gastroenterol Clin North Am. 2004 Sep; 33(3):479-96, vii-viii. Khalili M, Proietti N. PMID: 15324939.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    113. Daily versus thrice-weekly interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected persons: a multicenter randomized controlled trial. J Acquir Immune Defic Syndr. 2004 Apr 15; 35(5):464-72. Sulkowski MS, Felizarta F, Smith C, Slim J, Berggren R, Goodman R, Ball L, Khalili M, Dieterich DT, Hepatitis Resource Network Clinical Trials Group. PMID: 15021311.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    114. New onset diabetes mellitus after liver transplantation: the critical role of hepatitis C infection. Liver Transpl. 2004 Mar; 10(3):349-55. Khalili M, Lim JW, Bass N, Ascher NL, Roberts JP, Terrault NA. PMID: 15004760.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    115. Methods for quantifying insulin resistance in human immunodeficiency virus-positive patients. Metabolism. 2003 Jul; 52(7):858-61. Chu JW, Abbasi F, Beatty GW, Khalili M, Koch J, Rosen A, Schmidt JM, Stansell JD, Reaven GM. PMID: 12870161.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    116. Quantification of insulin-mediated glucose disposal in HIV-infected individuals: comparison of patients treated and untreated with protease inhibitors. J Acquir Immune Defic Syndr. 2003 May 01; 33(1):34-40. Beatty G, Khalili M, Abbasi F, Chu J, Reaven GM, Rosen A, Schmidt JM, Stansell J, Koch J. PMID: 12792353.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    117. Peiperl L, Volberding PA, eds. HIV InSite Knowledge Base [textbook on-line]. Coinfection with Hepatitis Viruses and HIV Update. 2003; Available from: HIV InSite. Khalili M.
    118. Hepatitis C in the setting of HIV co-infection. Microbes Infect. 2002 Oct; 4(12):1247-51. Khalili M, Behm BW. PMID: 12467766.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    119. [Long-term follow-up of 700 trabeculectomies]. Klin Monbl Augenheilkd. 2000 Jul; 217(1):1-8; discussion 9. Khalili MA, Diestelhorst M, Krieglstein GK. PMID: 10949810.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    120. Interferon and ribavirin versus interferon and amantadine in interferon nonresponders with chronic hepatitis C. Am J Gastroenterol. 2000 May; 95(5):1284-9. Khalili M, Denham C, Perrillo R. PMID: 10811340.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsCTClinical Trials
    121. Interferon Therapy of Hepatitis B. Clin Liver Dis. 1999; 3(2):363-87. Khalili M, Perrillo RP.
    122. Trabeculectomy: a retrospective follow-up of 700 eyes. Int Ophthalmol. 1998-1999; 22(4):211-20. Diestelhorst M, Khalili MA, Krieglstein GK. PMID: 10674865.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    123. Ionescu-Shiley valve failure. I: Experience with 125 standard-profile explants. Ann Thorac Surg. 1992 Jul; 54(1):111-6. Walley VM, Keon CA, Khalili M, Moher D, Campagna M, Keon WJ. PMID: 1610221.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    124. Ionescu-Shiley valve failure. II: Experience with 25 low-profile explants. Ann Thorac Surg. 1992 Jul; 54(1):117-22; discussion 122-3. Walley VM, Keon CA, Khalili M, Moher D, Campagna M, Keon WJ. PMID: 1610222.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    125. The University of Ottawa Heart Institute Cardiac Transplant Program: the first 100 transplants. A pathologic study of the explanted hearts. Mod Pathol. 1992 Mar; 5(2):158-64. Wolfsohn AL, Walley VM, Davies RA, Keon CA, Khalili M, Keon WJ. PMID: 1574494.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    Mandana's Networks
    Concepts (346)
    Derived automatically from this person's publications.
    _
    Co-Authors (71)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _